ATE494548T1 - Reinigung, charakterisierung und wiederherstellung einer ubiquitin-e3-ligase - Google Patents

Reinigung, charakterisierung und wiederherstellung einer ubiquitin-e3-ligase

Info

Publication number
ATE494548T1
ATE494548T1 AT06784518T AT06784518T ATE494548T1 AT E494548 T1 ATE494548 T1 AT E494548T1 AT 06784518 T AT06784518 T AT 06784518T AT 06784518 T AT06784518 T AT 06784518T AT E494548 T1 ATE494548 T1 AT E494548T1
Authority
AT
Austria
Prior art keywords
ubiquitin
complex
methods
ligase
characterization
Prior art date
Application number
AT06784518T
Other languages
English (en)
Inventor
Hengbin Wang
Ru Cao
Yi Zhang
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE494548T1 publication Critical patent/ATE494548T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/25—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving enzymes not classifiable in groups C12Q1/26 - C12Q1/66
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/9015—Ligases (6)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
AT06784518T 2005-06-02 2006-06-01 Reinigung, charakterisierung und wiederherstellung einer ubiquitin-e3-ligase ATE494548T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US68676905P 2005-06-02 2005-06-02
US75056405P 2005-12-15 2005-12-15
PCT/US2006/021159 WO2006130720A2 (en) 2005-06-02 2006-06-01 Purification, characterization and reconstitution of a ubiquitin e3 ligase

Publications (1)

Publication Number Publication Date
ATE494548T1 true ATE494548T1 (de) 2011-01-15

Family

ID=37482290

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06784518T ATE494548T1 (de) 2005-06-02 2006-06-01 Reinigung, charakterisierung und wiederherstellung einer ubiquitin-e3-ligase

Country Status (5)

Country Link
US (1) US7923219B2 (de)
EP (1) EP1891434B1 (de)
AT (1) ATE494548T1 (de)
DE (1) DE602006019423D1 (de)
WO (1) WO2006130720A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130102477A1 (en) 2010-06-23 2013-04-25 Ryan D. Morin Biomarkers for non-hodgkin lymphomas and uses thereof
US9175331B2 (en) 2010-09-10 2015-11-03 Epizyme, Inc. Inhibitors of human EZH2, and methods of use thereof
RU2765155C2 (ru) 2010-09-10 2022-01-26 Эпизайм, Инк. Ингибиторы ezh2 человека и способы их применения
TWI598336B (zh) 2011-04-13 2017-09-11 雅酶股份有限公司 經取代之苯化合物
JO3438B1 (ar) 2011-04-13 2019-10-20 Epizyme Inc مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
KR20220123339A (ko) 2012-04-13 2022-09-06 에피자임, 인코포레이티드 인간 히스톤 메틸트랜스퍼라제 ｅｚｈ２ 억제제의 염 형태
RU2658919C2 (ru) 2012-10-15 2018-06-26 Эпизайм, Инк. Замещенные бензольные соединения
AU2014247991B2 (en) * 2013-04-05 2019-05-09 Qiagen Sciences, Llc Kits and methods for isolating protein from biological and environmental samples
JP2016523517A (ja) * 2013-05-02 2016-08-12 イー３エックス バイオ インコーポレイテッド ユビキチンリガーゼのモジュレーターを同定するための方法
FI3057962T3 (fi) 2013-10-16 2023-11-03 Epizyme Inc Hydrokloridisuolamuoto ezh2-estoon
WO2017040992A1 (en) 2015-09-04 2017-03-09 Mo Bio Laboratories, Inc. Methods for co-isolation of nucelic acids and proteins
WO2018132825A2 (en) * 2017-01-16 2018-07-19 Memorial Sloan Kettering Cancer Center Treatment of sarcoma
WO2020264348A1 (en) * 2019-06-27 2020-12-30 Board Of Regents, The University Of Texas System Inhibitors of prc1 for treatment of cancer
KR102288716B1 (ko) * 2019-10-30 2021-08-12 경상남도 항비만 효능을 갖는 펩타이드 및 이의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6740495B1 (en) 2000-04-03 2004-05-25 Rigel Pharmaceuticals, Inc. Ubiquitin ligase assay
US6919184B2 (en) * 2000-04-03 2005-07-19 Rigel Pharmaceuticals, Inc. Assays for identifying ubiquitin agents and for identifying agents that modify the activity of ubiquitin agents
US7608682B2 (en) 2002-10-30 2009-10-27 Meso Scale Technologies Llc Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrates
GB0228900D0 (en) * 2002-12-11 2003-01-15 Ml Lab Plc Cancer Immunotherapy
EP1651595A2 (de) 2003-05-30 2006-05-03 Rigel Pharmaceuticals, Inc. Ubiquitinligaseinhibitoren

Also Published As

Publication number Publication date
US7923219B2 (en) 2011-04-12
DE602006019423D1 (de) 2011-02-17
EP1891434A2 (de) 2008-02-27
US20080248458A1 (en) 2008-10-09
WO2006130720A2 (en) 2006-12-07
EP1891434A4 (de) 2008-08-27
EP1891434B1 (de) 2011-01-05
WO2006130720A3 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
ATE494548T1 (de) Reinigung, charakterisierung und wiederherstellung einer ubiquitin-e3-ligase
DE602005017781D1 (de) Rekonstituierter histon-methyltransferase-komplex und verfahren zur identifizierung von modulatoren dafür
DE602006021223D1 (de) Verfahren zur identifizierung von trpv2-modulatoren
ATE404574T1 (de) Verfahren zur inhibierung der proliferation von tumorzellen, bei dem platinkomplexe eingesetzt werden
DK1587957T3 (da) Genekspressionsmarkør til prognose af brystkræft
WO2007016548A3 (en) Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
WO2003089904A3 (en) Aib1 as a prognostic marker and predictor of resistance to encocrine therapy
AR057800A1 (es) Compuestos ppar activos
WO2007064776A3 (en) Markers for breast cancer
NO20072179L (no) Kombinasjon av en SRC kinase inhibitor og en. BCR-ABL inhibitor for behandling av proleferative sykdommer
WO2006066024A8 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
DE602006002809D1 (de) Verfahren zur erkennung eines ovarialkarzinoms
WO2010045318A3 (en) Gene and gene expressed protein targets depicting biomarker patterns and signature sets by tumor type
NO20082386L (no) Ligander som har bindingsspesifisitet for EGFR og/eller VEGF og fremgangsmater for anvendelse derav
WO2005110479A3 (en) Treatments for pancreatic cancer
ATE533502T1 (de) Verfahren zur modulation der il-23-aktivität; relevante reagenzien
IL170669A0 (en) Anaplastic lymphoma kinase assay, reagents and compositions thereof
WO2003079020A3 (en) Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
WO2006078422A3 (en) Methods for modulating tumor growth and metastasis
ATE426039T1 (de) Verfahren fur den nachweis von streptococcus agalactiae mittels alpha-glucosidase-aktivitat
ATE514090T1 (de) Verwendung des proteins satb2 als marker zur unterscheidung kolorektaler karzinome von anderen krebserkrankungen
TW200700089A (en) Recombinant protein comprising starch binding domain and use thereof
WO2004101764A3 (en) Methods of modulating metastasis and skeletal related events resulting from metastases
ATE479778T1 (de) Verfahren zur diagnose nicht-kleinzelliger lungenkarzinome über die trna-dihydrouridin- synthaseaktivität von urlc8
WO2005070042A3 (en) Novel chemical compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties